Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis
Four months after tocilizumab was discontinued and antibiotic therapy was started, (a, b) ocular findings and (c, d) rashes on the palm and planta pedis are improving gradually. The ulcerative infected skin lesions gradually resolved (e), (f), and (g). (e) Two days after debridement. The skin lesions resolved (f) 4 and (g) 9 months after discontinuation of tocilizumab.